Lisanti Capital Growth, LLC Neogenomics Inc Transaction History

Lisanti Capital Growth, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$11.67 - $20.73 $2.48 Million - $4.41 Million	212,935 New	212,935 $3.45 Million
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $2.71 Million - $3.81 Million	-192,100 Reduced 36.37%	336,135 $5.4 Million
Q1 2023 May 05, 2023	BUY	$9.09 - $19.45 $4.8 Million - $10.3 Million	528,235 New	528,235 $9.2 Million
Q1 2021 May 12, 2021	SELL	$41.56 - $59.88 $4.81 Million - $6.93 Million	-115,748 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$36.08 - $56.47 $116,899 - $182,962	3,240 Added 2.88%	115,748 $6.23 Million
Q3 2020 Nov 05, 2020	BUY	$33.26 - $40.48 $3.74 Million - $4.55 Million	112,508 New	112,508 $4.15 Million
Q2 2020 Aug 10, 2020	SELL	$24.21 - $31.02 $3.69 Million - $4.73 Million	-152,391 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$20.5 - $34.53 $2.29 Million - $3.86 Million	111,926 Added 276.6%	152,391 $4.21 Million
Q4 2019 Feb 13, 2020	BUY	$18.96 - $29.84 $767,216 - $1.21 Million	40,465 New	40,465 $1.18 Million
Q3 2019 Nov 06, 2019	SELL	$19.12 - $26.24 $2.5 Million - $3.43 Million	-130,760 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$19.57 - $24.1 $2.56 Million - $3.15 Million	130,760 New	130,760 $2.87 Million

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.